De Maria R - Search Results

1

Modulation of fibronectin and thymic stromal cell-dependent thymocyte maturation by retinoic acid.

Meco D, Scarpa S, Napolitano M, Maroder M, Bellavia D, De Maria R, Ragano-Caracciolo M, Frati L, Modesti A, Gulino A, et al. Meco D, et al. Among authors: de maria r. J Immunol. 1994 Jul 1;153(1):73-83. J Immunol. 1994. PMID: 8207257

2

CD44 triggering enhances human NK cell cytotoxic functions.

Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A. Galandrini R, et al. Among authors: de maria r. J Immunol. 1994 Nov 15;153(10):4399-407. J Immunol. 1994. PMID: 7525702

3

Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity.

Palmieri G, Serra A, De Maria R, Gismondi A, Milella M, Piccoli M, Frati L, Santoni A. Palmieri G, et al. Among authors: de maria r. J Immunol. 1995 Dec 1;155(11):5314-22. J Immunol. 1995. PMID: 7594545

4

Epstein-Barr virus DNA is present both in CD10/CD77 positive and negative subsets of human tonsillar lymphocytes.

Cirone M, De Maria R, D'Alessandro A, Frati L, Faggioni A, Ragona G. Cirone M, et al. Among authors: de maria r. Cancer Lett. 1995 Feb 10;89(1):125-8. doi: 10.1016/0304-3835(95)90167-1. Cancer Lett. 1995. PMID: 7882294

5

The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

Testi R, D'Ambrosio D, De Maria R, Santoni A. Testi R, et al. Among authors: de maria r. Immunol Today. 1994 Oct;15(10):479-83. doi: 10.1016/0167-5699(94)90193-7. Immunol Today. 1994. PMID: 7945773 Review.

6

Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Giordano C, De Maria R, Todaro M, Stassi G, Mattina A, Richiusa P, Galluzzo G, Pantó F, Galluzzo A. Giordano C, et al. Among authors: de maria r. J Clin Immunol. 1993 Jan;13(1):68-78. doi: 10.1007/BF00920637. J Clin Immunol. 1993. PMID: 8095271

7

Defective T cell receptor/CD3 complex signaling in human type I diabetes.

De Maria R, Todaro M, Stassi G, Di Blasi F, Giordano M, Galluzzo A, Giordano C. De Maria R, et al. Eur J Immunol. 1994 Apr;24(4):999-1002. doi: 10.1002/eji.1830240433. Eur J Immunol. 1994. PMID: 8149968

8

Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes.

De Maria R, Fais S, Silvestri M, Frati L, Pallone F, Santoni A, Testi R. De Maria R, et al. Eur J Immunol. 1993 Dec;23(12):3104-8. doi: 10.1002/eji.1830231209. Eur J Immunol. 1993. PMID: 8258323

9

Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.

Cascino I, Papoff G, De Maria R, Testi R, Ruberti G. Cascino I, et al. Among authors: de maria r. J Immunol. 1996 Jan 1;156(1):13-7. J Immunol. 1996. PMID: 8598453

10

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.

Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C, De Maria R. Conticello C, et al. Among authors: de maria r. J Immunol. 2004 May 1;172(9):5467-77. doi: 10.4049/jimmunol.172.9.5467. J Immunol. 2004. PMID: 15100288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters